Assessment of Adherence and Relative Dose Intensity with Oral Chemotherapy in Oncology Clinical Trials at an Academic Medical Center

BACKGROUND/AIMS: Oral chemotherapy is increasingly utilized leaving the patient responsible for self-administering an often complex regimen where adverse effects are common. Non-adherence and reduced relative dose intensity (RDI) are both associated with poorer outcomes in the community setting but...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Oncol Pharm Pract
Autors principals: Engle, Jeff A., Traynor, Anne M., Campbell, Toby, Wisinski, Kari B., LoConte, Noelle, Liu, Glenn, Wilding, George, Kolesar, Jill M.
Format: Artigo
Idioma:Inglês
Publicat: 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5932265/
https://ncbi.nlm.nih.gov/pubmed/28457192
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1078155217704989
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars